ProQuest Associates IV LLC, 10% Owner at EAGLE PHARMACEUTICALS, INC. (EGRX), sold 296,099 shares at $70.00 ($21.0M) on 2016-11-02, disclosed to the SEC on 2016-11-04.
Open-market sale of $21.0M EGRX by 10% Owner. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $70.00 | 800 | $56K | 0.3% |
| 2 | $70.00 | 2,100 | $147K | 0.7% |
| 3 | $70.00 | 146,371 | $10.2M | 48.8% |
| 4 | $70.41 | 50,329 | $3.5M | 16.9% |
| 5 | $70.41 | 50,329 | $3.5M | 16.9% |
| 6 | $75.00 | 46,170 |
| $3.5M |
| 16.5% |
| Total | $70.92 avg | 296,099 | $21.0M | 100% |
| Filing → |
| EGRX | SELL | 2017-01-06 | $11.1M | — | Filing → |
| EGRX | SELL | 2016-11-14 | $4.2M | — | Filing → |
| EGRX | SELL | 2016-09-30 | $10.9M | — | Filing → |